You are here: Industry Insights > COVID-19

News List

Covid-19 vaccine distribution– A daunting task, but there is a way out expresspharma
November 30, 2020
The unprecedented pandemic and the havoc wrecked by COVID-19 have brought the leaders of scientific community all over the world together and the sharpest of the minds have been relentlessly working towards a solution to address this.
Russia to vaccinate armed forces against COVID-19 as new cases hit daily record expresspharma
November 30, 2020
Russia plans to vaccinate more than 400,000 military personnel against COVID-19, Defence Minister Sergei Shoigu said on Friday, as authorities reported a record 27,543 new coronavirus cases.
WHO says would be ‘highly speculative’ to say COVID did not emerge in China expresspharma
November 30, 2020
China is pushing a narrative via state media that the virus existed abroad before it was discovered in the central city of Wuhan.
Govt extends validity of import licence & registration certificate by six months expresspharma
November 30, 2020
With an aim to ensure the availability of medicines amidst the prevailing corona virus in the country, the government has given an extension of six months for the validity of import licence (Form-10).
Modi visits key vaccine facilities as COVID-19 case load surges expresspharma
November 30, 2020
The companies are testing homegrown vaccine options, as well as working on trials of vaccines being developed overseas.
Half of top 20 global innovative pharma companies MCap reported positive growth in Q3 2020- GlobalData expresspharma
November 27, 2020
Half of the companies in a ranking of top 20 global innovative pharmaceutical firms by data and analytics company GlobalData reported positive market capitalization (MCap) growth in Q3, with Pfizer and Daiichi Sankyo Co reporting double-digit percentage..
Doctors use existing treatment earlier to save the lives of COVID-19 patients worldpharmanews
November 27, 2020
The lives of patients hospitalised with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.
Health Canada clears Appili Therapeutics for new phase 3 trial to assess Avigan to prevent Covid-19 pharmaceutical-business-review
November 27, 2020
Appili Therapeutics, a biopharmaceutical company focused on anti-infective drug development, announced initiation of its Phase 3 Post Exposure Prophylaxis for COVID-19 (PEPCO) study to evaluate Avigan tablets (favipiravir) in the prevention of Covid-19.
Trial to compare dexamethasone and baricitinib in hospitalised COVID-19 patients europeanpharmaceuticalreview
November 27, 2020
The fourth iteration of the COVID-19 treatment trial will determine whether remdesivir plus baricitinib or dexamethasone, is more effective at promoting recovery from COVID-19.
CaptiGen, LLC Announces Enhanced Covid-19 Testing prnewswire
November 26, 2020
CaptiGen, LLC is pleased to announce the development of CaptiSwab, sterile, individually wrapped, knitted textile swabs for the collection of clinical samples for microbial detection through standard culture, RT-PCR, and next-generation sequencing (NGS).